Physician profile

Tan N Pham

Endocrinology, Diabetes & Metabolism · Norman, OK

NPI 1740259076

$7,420.99

in general payments reported to CMS, 2019-2025

48 companies · $767 in 2025

The $767 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

See the full distribution for Endocrinology, Diabetes & Metabolism

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,608.10
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$425.00
Education$19.62

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $1,040.90 2019-2025 Jardiance, Mounjaro, Zepbound
Novo Nordisk INC $874.18 2019-2025 Ozempic, Rybelsus
Tandem Diabetes Care, INC. $729.14 2019-2025 T:Slim X2 Insulin Pump With Control-Iq
Sanofi-Aventis U.S. LLC $361.82 2019-2025
Dexcom, INC. $326.01 2021-2025 Dexcom G6 Transmitter
Xeris Pharmaceuticals, INC. $325.53 2021-2025 Recorlev, Gvoke Hypopen
Insulet Corporation $284.05 2021-2024 Omnipod
Astrazeneca Pharmaceuticals LP $263.22 2019-2023 Farxiga
Janssen Pharmaceuticals, INC $256.12 2019-2020
Radius Health, INC. $241.70 2023-2025 Tymlos
Amgen INC. $239.34 2019-2025 Tepezza, Prolia, Evenity
Abbott Laboratories $207.27 2019-2025 Freestyle Libre 3
Corcept Therapeutics $195.69 2019-2025 Korlym
Abbvie INC. $171.65 2019-2024
Bayer Healthcare Pharmaceuticals INC. $168.67 2023-2025
Show all 48 companies
CompanyGeneral paymentsYearsTop products
Antares Pharma, INC. $140.69 2019-2024 Xyosted, Tlando, Nocdurna
Ibsa Pharma INC. $135.22 2019-2023 Tirosint, Licart
Merck Sharp & Dohme LLC $123.37 2019-2023 Steglatro
Medtronic, INC. $121.28 2023-2025 Intellis Adaptivestim, Minimed 780g, Inceptiv
Madrigal Pharmaceuticals $117.78 2024-2025 Rezdiffra, Resmetirom
Amarin Pharma, INC. $96.31 2019-2020
Lifescan, INC. $93.04 2019-2022
Chiesi USA, INC. $87.16 2024 Mycapssa
Recordati_rare_diseases_inc. $78.23 2020-2025 Isturisa
Boehringer Ingelheim Pharmaceuticals, INC. $77.40 2019-2023 Tradjenta, Synjardy, Jardiance
Ascensia Diabetes Care US INC. $53.41 2023-2024
Alexion Pharmaceuticals, INC. $51.29 2024-2025 Strensiq
Ipsen Biopharmaceuticals, INC $47.66 2019-2020
Cequr Corporation $46.00 2022-2025 Cequr Simplicity
Mannkind Corporation $45.41 2023 Afrezza
Ultragenyx Pharmaceutical INC. $44.13 2022
Amryt Pharma Holdings LTD $41.84 2022
Currax Pharmaceuticals LLC $39.42 2021-2023 Onzetra Xsail, Contrave
Endo Pharmaceuticals INC. $35.83 2019-2022
Sequel Med Tech, LLC $29.20 2025 Twiist
Horizon Therapeutics Plc $25.86 2021
Baxter Healthcare $22.25 2025 Perclot
Ascendis Pharma Endocrinology INC $19.58 2025 Yorvipath
Eisai INC. $19.57 2019
Gilead Sciences, INC. $19.07 2019
Echosens North America, INC. $18.94 2024 Fibroscan
Beta Bionics, INC. $18.81 2025 Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach
Hologic Sales and Service, LLC $18.28 2023 Coolseal Generator
Halozyme INC $15.59 2023
Amneal Pharmaceuticals LLC $14.81 2024 Unithroid
Medtronic Minimed, INC. $13.78 2020
Shire North American Group INC $12.51 2019
Valeritas, INC. $11.98 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Tan N Pham

$7,420.99

in general payments reported 2019-2025

Years
2019-2025
Top company
Lilly USA, LLC
Context
The $767 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).

https://glasscript.com/doctor/260243/tan-n-pham

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.